Trial · NCT01229449
Adverse events30
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 30
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Nausea | Gastrointestinal disorders | Ibuprofen 200mg + Paracetamol 500mg (Lower Dose) | 43 | 173 | 49 |
| other | Nausea | Gastrointestinal disorders | Ibuprofen 400mg + Paracetamol 1000mg (Higher Dose) | 33 | 168 | 36 |
| other | Nausea | Gastrointestinal disorders | Nurofen Plus® | 50 | 169 | 57 |
| other | Nausea | Gastrointestinal disorders | Panadeine® Extra | 37 | 113 | 49 |
| other | Nausea | Gastrointestinal disorders | Placebo | 18 | 55 | 19 |
| other | Vomiting | Gastrointestinal disorders | Ibuprofen 200mg + Paracetamol 500mg (Lower Dose) | 29 | 173 | 32 |
| other | Vomiting | Gastrointestinal disorders | Ibuprofen 400mg + Paracetamol 1000mg (Higher Dose) | 30 | 168 | 34 |
| other | Vomiting | Gastrointestinal disorders | Nurofen Plus® | 35 | 169 | 41 |
| other | Vomiting | Gastrointestinal disorders | Panadeine® Extra | 25 | 113 | 29 |
| other | Vomiting | Gastrointestinal disorders | Placebo | 13 | 55 | 13 |
| other | Dizziness | Nervous system disorders | Ibuprofen 200mg + Paracetamol 500mg (Lower Dose) | 12 | 173 | 13 |
| other | Dizziness | Nervous system disorders | Ibuprofen 400mg + Paracetamol 1000mg (Higher Dose) | 15 | 168 | 16 |
| other | Dizziness | Nervous system disorders | Nurofen Plus® | 23 | 169 | 24 |
| other | Dizziness | Nervous system disorders | Panadeine® Extra | 14 | 113 | 14 |
| other | Dizziness | Nervous system disorders | Placebo | 3 | 55 | 4 |
| other | Headache | Nervous system disorders | Ibuprofen 200mg + Paracetamol 500mg (Lower Dose) | 19 | 173 | 23 |
| other | Headache | Nervous system disorders | Ibuprofen 400mg + Paracetamol 1000mg (Higher Dose) | 19 | 168 | 21 |
| other | Headache | Nervous system disorders | Nurofen Plus® | 32 | 169 | 35 |
| other | Headache | Nervous system disorders | Panadeine® Extra | 21 | 113 | 30 |
| other | Headache | Nervous system disorders | Placebo | 10 | 55 | 11 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01229449/events